Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ZANTAC IN PLASTIC CONTAINER

RANITIDINE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ZANTAC IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019593 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient RANITIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/100ML Sponsor PAI HOLDINGS PHARM Submission history Latest submission status date: 2009-09-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZANTAC IN PLASTIC CONTAINER is listed in Drugs@FDA under application 019593 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RANITIDINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 50MG BASE/100ML Sponsor PAI HOLDINGS PHARM Submission history Latest submission status date: 2009-09-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ZANTAC IN PLASTIC CONTAINER (RANITIDINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline